Although haploinsufficient-related mutations in OPA1 lead to optic atrophy, dominant gain-of-function mutations in OPA1 cause more severe phenotypes of optic atrophy, often concomitant with deafness, axonal neuropathy, ataxia, and/or myopathy. This evidence concerns the gene OPA1 and myopathy.